Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Zhonghua Xue Ye Xue Za Zhi ; 43(1): 26-30, 2022 Jan 14.
Artigo em Chinês | MEDLINE | ID: mdl-35231989

RESUMO

Objective: To analyze the clinical characteristics, laboratory examination, diagnosis, treatment, and outcome of hereditary factor Ⅹ (FⅩ) deficiency. Methods: Clinical data of 11 patients with congenital FⅩ deficiency were retrospectively analyzed from July 2009 to February 2021. Results: There were 3 males and 8 females. Median age was 39 (5-55) years. The media duration of follow-up was 81.67 (1.87-142.73) months. Of the 11 patients, 10 had bleeding symptoms, 7 had ecchymosis or hemorrhage after skin bump, 7 had nosebleed, 6 had gingival hemorrhage, and 1 had muscle hematoma. Among the female patients, 6 had menorrhagia and 1 experienced bleeding after vaginal delivery. Family history of FⅩ deficiency was found in one case. Eight patients had a history of surgery, and four had postoperative bleeding. Laboratory findings were characterized by significantly prolonged activated partial thromboplastin time, prothrombin time, and decreased FⅩ activity (FⅩ∶C) . Four cases underwent gene mutation analysis and five new mutations were found. Four cases were treated with prothrombin complex concentrates (PCC) and seven cases with fresh frozen plasma (FFP) . One female patient had significantly reduced menstrual volume after PCC prophylactic therapy. One patient received FFP for prophylactic infusion with no bleeding during and after the operation. Conclusion: Most patients with congenital FⅩ deficiency had bleeding symptoms and there was no significant correlation between severity of bleeding symptoms and FⅩ∶C. Prophylaxis should be applied in patients with severe bleeding tendencies. Gene mutation test is significant for screening, diagnosis, and prognosis prediction of congenital FX deficiency.


Assuntos
Deficiência do Fator X , Adolescente , Adulto , Fatores de Coagulação Sanguínea/uso terapêutico , Testes de Coagulação Sanguínea , Criança , Pré-Escolar , Deficiência do Fator X/genética , Feminino , Hemorragia/tratamento farmacológico , Humanos , Masculino , Pessoa de Meia-Idade , Plasma , Estudos Retrospectivos , Adulto Jovem
2.
Genet Mol Res ; 14(4): 16178-84, 2015 Dec 08.
Artigo em Inglês | MEDLINE | ID: mdl-26662410

RESUMO

Chromosomal abnormality is the most common genetic cause of male infertility, particularly in cases of azoospermia, oligozoospermia, and recurrent spontaneous abortion. Chromosomal rearrangement may interrupt an important gene or exert position effects. The functionality of genes at specific breakpoints, perhaps with a specific role in spermatogenesis, may be altered by such rearrangements. Structural chromosome abnormalities are furthermore known to increase the risk of pregnancy loss. In this study, we aimed to assess chromosomal defects in infertile men from Jilin Province, China, by genetic screening and to evaluate the relationship between structural chromosome abnormalities and male infertility. The prevalence of chromosomal abnormalities among the study participants (receiving genetic counseling in Jilin Province, China) was 10.55%. The most common chromosome abnormality was Klinefelter syndrome, and the study findings suggested that azoospermia and oligospermia may result from structural chromosomal abnormalities. Chromosome 1 was shown to be most commonly involved in male infertility and balanced chromosomal translocation was identified as one of the causes of recurrent spontaneous abortion. Chromosomes 4, 7, and 10 were the most commonly involved chromosomes in male partners of women experiencing repeated abortion.


Assuntos
Aberrações Cromossômicas , Testes Genéticos , Infertilidade Masculina/diagnóstico , Infertilidade Masculina/genética , Adolescente , Adulto , Azoospermia/diagnóstico , Azoospermia/epidemiologia , Azoospermia/genética , China/epidemiologia , Aconselhamento Genético , Testes Genéticos/métodos , Humanos , Infertilidade Masculina/epidemiologia , Cariótipo , Cariotipagem , Masculino , Programas de Rastreamento , Pessoa de Meia-Idade , Oligospermia/diagnóstico , Oligospermia/epidemiologia , Oligospermia/genética , Análise do Sêmen , Adulto Jovem
3.
Eur J Surg Oncol ; 41(8): 958-66, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-26054706

RESUMO

BACKGROUND: In early breast cancer patients with sentinel node metastasis, the effect of axillary lymph node dissection (ALND) is controversial. The purpose of this study is to compare the safety and efficacy of sentinel lymph node biopsy (SLNB) alone versus ALND in patients with early breast cancer and sentinel node metastasis. METHODS: We searched PubMed, Embase, Web of Science, and Cochrane Library databases from 1965 to February 2014. All data were analyzed using Review Manager Software 5.2. RESULTS: 12 studies, which included 130,575 patients from five randomized controlled trials and seven observational studies, met our inclusion criteria. 26,870 early breast cancer patients underwent SLNB alone and 103,705 underwent ALND. Patients underwent ALND had more paresthesia (risk ratio [RR] 0.26, 95% confidence interval [CI] 0.20-0.33; p < 0.01) and lymphedema (RR 0.28, 95% CI 0.20-0.41; p < 0.01) than those had SLNB alone. There were no significant differences in overall survival (hazard ratio [HR] 0.95, 95% CI 0.85-1.06; p = 0.35), disease-free survival (HR 1.00, 95% CI 0.98-1.02, p = 0.96), and locoregional recurrence (RR 0.92, 95% CI 0.59-1.44; p = 0.73). CONCLUSION: Current evidence indicates that axillary dissection may be omitted in early breast cancer patients with sentinel lymph metastasis.


Assuntos
Neoplasias da Mama/secundário , Diagnóstico Precoce , Excisão de Linfonodo/métodos , Linfonodos/patologia , Biópsia de Linfonodo Sentinela/métodos , Axila , Neoplasias da Mama/diagnóstico , Feminino , Humanos , Linfonodos/cirurgia , Metástase Linfática
4.
J Dairy Sci ; 97(7): 4193-207, 2014 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-24767884

RESUMO

Molecular mechanisms regulating rumen epithelial development remain largely unknown. To identify gene networks and regulatory factors controlling rumen development, Holstein bull calves (n=18) were fed milk replacer only (MRO) until 42 d of age. Three calves each were euthanized at 14 and 42 d of age for tissue collection to represent preweaning, and the remaining calves were provided diets of either milk replacer + orchard grass hay (MH; n=6) to initiate weaning without development of rumen papillae, or milk replacer + calf starter (MG; n=6) to initiate weaning and development of rumen papillae. At 56 and 70 d of age, 3 calves from the MH and MG groups were euthanized for collection of rumen epithelium. Total RNA and protein were extracted for microarray analysis and to validate detected changes in selected protein expression, respectively. As expected, calves fed MRO had no rumen papillae and development of papillae was greater in MG versus MH calves. Differentially expressed genes between the MRO diet at d 42 (preweaning) versus the MG or MH diets at d 56 (during weaning) were identified using permutation analysis of differential expression. Expression of 345 and 519 transcripts was uniquely responsive to MG and MH feeding, respectively. Ingenuity Pathway Analysis (Qiagen, Redwood City, CA) indicated that the top-ranked biological function affected by the MG diet was the cell cycle, and TFGB1, FBOX01, and PPARA were identified as key transcriptional regulators of genes responsive to the MG diet and associated with development of rumen papillae. Increased expressions of TGFB1 mRNA and protein in response to the MG diet were confirmed by subsequent analyses. The top-ranking biological function affected by the MH diet was energy production. Receptors for IGF-1 and insulin, ESRRA, and PPARD were identified by ingenuity pathway analysis as transcriptional regulators of genes responsive to the MH diet. Further analysis of TGFB1 and ESRRA mRNA expression in rumen epithelium obtained from a separate ontogenic study of Holstein calves (n=26) euthanized every 7d from birth to 42 d of age showed increases in transcript expression with advancing age, supporting their roles in mediating rumen epithelial development and function during weaning. Additional evaluation of gene expression in the rumen epithelium of adult cows ruminally infused with butyrate also suggested that observed changes in ESRRA mRNA expression in developing calf rumen may be mediated by increased butyrate concentration. Our results identify TGFB1 and ESRRA as likely transcriptional regulators of rumen epithelial development and energy metabolism, respectively, and provide targets for modulation of rumen development and function in the growing calf.


Assuntos
Bovinos/crescimento & desenvolvimento , Regulação da Expressão Gênica no Desenvolvimento , Receptores de Estrogênio/genética , Fator de Crescimento Transformador beta1/genética , Desmame , Animais , Bovinos/genética , Bovinos/metabolismo , Epitélio/crescimento & desenvolvimento , Epitélio/metabolismo , Mucosa Gástrica/crescimento & desenvolvimento , Mucosa Gástrica/metabolismo , Redes Reguladoras de Genes , Genoma , Masculino , Receptores de Estrogênio/metabolismo , Rúmen/crescimento & desenvolvimento , Rúmen/metabolismo , Fator de Crescimento Transformador beta1/metabolismo , Receptor ERRalfa Relacionado ao Estrogênio
5.
Acta Biomater ; 10(3): 1463-74, 2014 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-24291328

RESUMO

A simple strontium phosphate (SrP) conversion coating process was developed to protect magnesium (Mg) from the initial degradation post-implantation. The coating morphology, deposition rate and resultant phases are all dependent on the processing temperature, which determines the protective ability for Mg in minimum essential medium (MEM). Coatings produced at 80 °C are primarily made up of strontium apatite (SrAp) with a granular surface, a high degree of crystallinity and the highest protective ability, which arises from retarding anodic dissolution of Mg in MEM. Following 14 days' immersion in MEM, the SrAp coating maintained its integrity with only a small fraction of the surface corroded. The post-degradation effect of uncoated Mg and Mg coated at 40 and 80 °C on the proliferation and differentiation of human mesenchymal stem cells was also studied, revealing that the SrP coatings are biocompatible and permit proliferation to a level similar to that of pure Mg. The present study suggests that the SrP conversion coating is a promising option for controlling the early rapid degradation rate, and hence hydrogen gas evolution, of Mg implants without adverse effects on surrounding cells and tissues.


Assuntos
Materiais Revestidos Biocompatíveis/farmacologia , Magnésio/farmacologia , Fosfatos/farmacologia , Estrôncio/farmacologia , Fosfatase Alcalina/metabolismo , Diferenciação Celular/efeitos dos fármacos , Meios de Cultura , Técnicas Eletroquímicas , Humanos , Hidrogênio/análise , Células-Tronco Mesenquimais/citologia , Células-Tronco Mesenquimais/efeitos dos fármacos , Células-Tronco Mesenquimais/enzimologia , Microscopia Eletrônica de Varredura , Osteogênese/efeitos dos fármacos , Espectroscopia Fotoeletrônica , Propriedades de Superfície , Temperatura , Difração de Raios X
6.
Animal ; 6(3): 382-93, 2012 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-22436217

RESUMO

Mammary stem cells (MaSC) provide for net growth, renewal and turnover of mammary epithelial cells, and are therefore potential targets for strategies to increase production efficiency. Appropriate regulation of MaSC can potentially benefit milk yield, persistency, dry period management and tissue repair. Accordingly, we and others have attempted to characterize and alter the function of bovine MaSC. In this review, we provide an overview of current knowledge of MaSC gained from studies using mouse and human model systems and present research on bovine MaSC within that context. Recent data indicate that MaSC retain labeled DNA for extended periods because of their selective segregation of template DNA strands during mitosis. Relying on this long-term retention of bromodeoxyuridine-labeled DNA, we identified putative bovine MaSC. These label-retaining epithelial cells (LREC) are in low abundance within mammary epithelium (<1%). They are predominantly estrogen receptor (ER)-negative and localized in a basal or suprabasal layer of the epithelium throughout the gland. Thus, the response of MaSC to estrogen, the major mitogen in mammary gland, is likely mediated by paracrine factors released by cells that are ER-positive. This is consistent with considerable evidence for cross-talk within and between epithelial cells and surrounding stromal cells. Excision of classes of cells by laser microdissection and subsequent microarray analysis will hopefully provide markers for MaSC and insights into their regulation. Preliminary analyses of gene expression in laser-microdissected LREC and non-LREC are consistent with the concept that LREC represent populations of stem cells and progenitor cells that differ with regard to their properties and location within the epithelial layer. We have attempted to modulate the MaSC number by infusing a solution of xanthosine through the teat canal and into the ductal network of the mammary glands of prepubertal heifers. This treatment increased the number of putative stem cells, as evidenced by an increase in the percentage of LREC and increased telomerase activity within the tissue. The exciting possibility that stem cell expansion can influence milk production is currently under investigation.


Assuntos
Células-Tronco Adultas/citologia , Bovinos , Células Epiteliais/citologia , Glândulas Mamárias Animais/citologia , Células-Tronco Adultas/metabolismo , Animais , Bovinos/fisiologia , Proliferação de Células , Indústria de Laticínios , Células Epiteliais/metabolismo , Feminino , Expressão Gênica , Lactação , Glândulas Mamárias Animais/efeitos dos fármacos , Leite/metabolismo
7.
Parasite Immunol ; 33(12): 669-78, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21958368

RESUMO

Galectin-11 (LGALS11) has been suggested to play an important role in protective immunity against gastrointestinal nematodes in ruminants. However, in cattle, this molecule has not been characterized in detail. In the current study, it was shown that transcription of LGALS11 was highly inducible in the bovine abomasal mucosa after an Ostertagia ostertagi infection. LGALS11 protein expression was also increased in the abomasal mucosa following O. ostertagi infection and localized to the nucleus and cytoplasm of epithelial cells and the mucus. Using in vitro abomasal epithelial cell cultures, it was shown that LGALS11 induction was associated with the proliferative and dedifferentiated status of cells. However, LGALS11 was not induced following stimulation with O. ostertagi excretory-secretory products. These results suggest that LGALS11 induction in vivo may be an indirect rather than a direct effect of the parasite on the epithelium. In addition, LGALS11 transcript was also detected in the abomasal lymph nodes where it was shown to be transcribed in MHCII+ cells; however, transcription levels in the lymph nodes were not altered after O. ostertagi infection. In addition, LGALS11 was also induced in the small intestine by different types of parasites, including the nematode Cooperia oncophora and the protozoan parasite Giardia duodenalis.


Assuntos
Doenças dos Bovinos/imunologia , Doenças dos Bovinos/parasitologia , Galectinas/biossíntese , Trato Gastrointestinal/imunologia , Trato Gastrointestinal/parasitologia , Ostertagíase/veterinária , Animais , Bovinos , Proliferação de Células , Células Cultivadas , Células Epiteliais/imunologia , Perfilação da Expressão Gênica , Mucosa Intestinal/imunologia , Ostertagia/imunologia , Ostertagia/patogenicidade , Ostertagíase/imunologia , Rúmen/imunologia
8.
Am J Physiol Heart Circ Physiol ; 295(3): H1177-H1181, 2008 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-18641267

RESUMO

The involvement of ecto-5'-nucleotidase (E-5'Nu) in the elevation of extracellular adenosine during inflammation is unclear. In the present study, the effect of lipopolysaccharide (LPS), an inflammation inducer, was investigated on E-5'Nu in human umbilical vein endothelial cells (HUVECs). E-5'Nu activity was enhanced after a 24 h exposure to LPS. This effect was dose dependent, with an EC50 of 1.66 ng/ml. At 10 microM, the phosphatidylinositol 3-kinase (PI3K) inhibitor LY-294002 abolished the LPS-induced E-5'Nu activity. However, at 10 microM, the NF-kappaB inhibitor ammonium pyrrolidine dithiocarbamate had no effect. LPS upregulated the protein expression but not the messenger RNA expression of E-5'Nu. The inhibition of E-5'Nu by 100 microM alpha,beta-methylene adenosine-5'-diphosphate increased the LPS-induced inflammation, suggesting that E-5'Nu plays a significant role in reducing inflammation, probably through the generation of adenosine. In conclusion, the experiments indicate that LPS upregulates E-5'Nu activity in HUVECs through a PI3K-dependent increase in the abundance of E-5'Nu on cell membranes. Since adenosine is an anti-inflammatory molecule, E-5'Nu upregulation may be crucial in protecting endothelial cells against inflammatory damage.


Assuntos
5'-Nucleotidase/metabolismo , Células Endoteliais/enzimologia , Lipopolissacarídeos/farmacologia , Veias Umbilicais/enzimologia , 5'-Nucleotidase/antagonistas & inibidores , Antagonistas do Receptor A2 de Adenosina , Western Blotting , Células Cultivadas , Cromonas/farmacologia , Relação Dose-Resposta a Droga , Células Endoteliais/efeitos dos fármacos , Inibidores Enzimáticos/farmacologia , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Interleucina-8/biossíntese , Morfolinas/farmacologia , NF-kappa B/antagonistas & inibidores , Fosfatidilinositol 3-Quinases/metabolismo , Gravidez , RNA/biossíntese , RNA/isolamento & purificação , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Estimulação Química , Veias Umbilicais/citologia , Veias Umbilicais/efeitos dos fármacos , Molécula 1 de Adesão de Célula Vascular/biossíntese
9.
J Dairy Sci ; 90 Suppl 1: E55-65, 2007 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-17517752

RESUMO

It is well established that estrogen is required for mammary epithelial cell proliferation and ductal development in the growing animal, and that lobuloalveolar development during gestation is dependent on progesterone. The effects of these steroid hormones on gene expression in the mammary gland are mediated primarily by their respective nuclear hormone receptors, which function as hormone-bound transcription factors. To gain insight into how estrogen and progesterone regulate mammary gland growth and function in cattle, we and others have characterized the expression patterns of their cognate nuclear hormone receptors in the bovine mammary gland throughout development, pregnancy, and lactation. This work has identified a lack of expression of estrogen receptor beta and a greater abundance of progesterone receptor during lactation in the bovine mammary gland, compared with the rodent gland. We speculate that interactions among the estrogen receptor isoforms that regulate progesterone receptor expression may contribute to these species differences. Further, demonstrated expression of substantial quantities of estrogen receptor within the prepubertal bovine mammary fat pad, along with coordinated insulin-like growth factor-I expression, suggests that this tissue may stimulate parenchymal growth via an estrogen-responsive paracrine mechanism. In addition, the recent availability of bovine genomic sequence information and microarray technologies has permitted the study of global gene expression in the mammary gland in response to the steroid environment. We have identified more than 100 estrogen-responsive genes, of which the majority are novel estrogen gene targets. Estrogen-induced changes in gene expression were consistent with increased mammary epithelial cell proliferation, increased extracellular matrix turnover in parenchyma, and increased extracellular matrix deposition in the fat pad. A comparison of estrogen-responsive genes in the mammary glands of humans, mice, and cattle suggests considerable variation among species, as well as potential differences in regulatory elements in common estrogen receptor gene targets. Continuing studies using advanced molecular techniques should assist in elucidating the complex regulation of mammary function at the transcript level.


Assuntos
Regulação da Expressão Gênica , Lactação/metabolismo , Glândulas Mamárias Animais/metabolismo , Receptores de Estrogênio/análise , Receptores de Progesterona/análise , Animais , Bovinos , Estrogênios/metabolismo , Estrogênios/fisiologia , Feminino , Glândulas Mamárias Animais/crescimento & desenvolvimento , Análise em Microsséries , Gravidez , Progesterona/metabolismo , Progesterona/fisiologia , Isoformas de Proteínas/análise , Isoformas de Proteínas/genética , Receptores de Estrogênio/genética , Receptores de Progesterona/genética
10.
Shanghai Kou Qiang Yi Xue ; 5(4): 189-91, 1996 Dec.
Artigo em Chinês | MEDLINE | ID: mdl-15159980

RESUMO

44 cases of oral squamous cell carcinoma under 40 years old were analyzed retrospectively.The ratio of male to female was 1.93:1,the youngest was 3,and the majority were within 30-40 years old.The predict site was on the tongue,21 cases shown and accounting for 66.90%.Histologically,the most cases were highly differentiated,accounting for 81092%.About one half cases were present in the terminal clinical stage,and for tongue cancer,terminal stage cases were as high as 61.90%.The patients did not cooperate with treatment very well,only minority could fulfill combined therapy in strict meaning.The recurrence was high and might affected the prognosis.The results were discussed and literatures were reviewed.

12.
Cancer Treat Rep ; 61(8): 1499-508, 1977 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-922753

RESUMO

Antileukemia sera with "directed" specificity are produced by immunization of rabbits with mouse leukemia cells admixed with normal antigen blocking (NAB) serum. Addition of NAB serum to the leukemia cells inhibits production of antibodies to normal cell components and directs specificity toward leukemia cell antigens. The resulting antileukemia serum (ALK-NABS) was not sufficiently potent to produce more than moderate therapy in the standard L1210 leukemia therapy assay. When given together with noncurative doses of cyclophosphamide (CTX), ALK-NABS acts synergistically. It is most effective when given early after injection of the leukemia cells and prior to injection of CTX. Daily repeated injections of a given dose are more effective than a single injection of that dose. Most important, small doses of ALK-NABS produce a significant prolongation of lifespan in conjunction with CTX. Results of therapy for BW-A leukemia with ALK-NABS in conjunction with CTX were negative.


Assuntos
Ciclofosfamida/uso terapêutico , Imunização Passiva , Leucemia Experimental/terapia , Animais , Especificidade de Anticorpos , Ciclofosfamida/administração & dosagem , Esquema de Medicação , Leucemia L1210/terapia , Camundongos , Camundongos Endogâmicos AKR , Camundongos Endogâmicos DBA
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA